Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis

Cherian, 2010, Abdominal pain is a frequent symptom of gastroparesis, Clin Gastroenterol Hepatol, 8, 676, 10.1016/j.cgh.2010.04.027 Hasler, 2013, Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting, Neurogastroenterol Motil, 25, 10.1111/nmo.12091 Jeong, 2012, A randomized, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans, Aliment Pharmacol Ther, 35, 1088 Gonenne, 2005, Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study, Clin Gastroenterol Hepatol, 3, 784, 10.1016/S1542-3565(05)00434-9 Yuan, 1998, Effects of low-dose morphine on gastric emptying in healthy volunteers, J Clin Pharmacol, 38, 1017, 10.1177/009127009803801105 Kalso, 2004, Opioids in chronic non-cancer pain: systematic review of efficacy and safety, Pain, 112, 372, 10.1016/j.pain.2004.09.019 Tuteja, 2010, Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain, Neurogastroenterol Motil, 22, 424, 10.1111/j.1365-2982.2009.01458.x Porreca, 2009, Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options, Pain Med, 10, 654, 10.1111/j.1526-4637.2009.00583.x Vorsanger, 2011, Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients, Pain Res Manag, 16, 245, 10.1155/2011/323985 Buynak, 2010, Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled phase III study, Expert Opin Pharmacother, 11, 1787, 10.1517/14656566.2010.497720 Vorsanger, 2010, Evaluation of study discontinuations with tapentadol immediate release and oxycodone immediate release in patients with low back or osteoarthritis pain, J Opioid Manag, 6, 169, 10.5055/jom.2010.0015 Tougas, 2000, Assessment of gastric emptying using a low fat meal: establishment of international control values, Am J Gastroenterol, 95, 1456, 10.1111/j.1572-0241.2000.02076.x Anderson, 2001, Accuracy in equianalgesic dosing. Conversion dilemmas, J Pain Symptom Manage, 21, 397, 10.1016/S0885-3924(01)00271-8 Sachdeva, 2011, Gastric emptying of solids and liquids for evaluation for gastroparesis, Dig Dis Sci, 56, 1138, 10.1007/s10620-011-1635-9 Abell, 2008, Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine, Am J Gastroenterol, 103, 753, 10.1111/j.1572-0241.2007.01636.x Rentz, 2004, Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders, Qual Life Res, 13, 1737, 10.1007/s11136-004-9567-x Revicki, 2003, Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index, Aliment Pharmacol Ther, 18, 141, 10.1046/j.1365-2036.2003.01612.x De la Loge, 2004, Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL, Qual Life Res, 13, 1751, 10.1007/s11136-004-8751-3 Akaike, 1974, A new look at the statistical model identification, IEEE Trans Autom Control, 19, 716, 10.1109/TAC.1974.1100705 Bender, 2001, Adjusting for multiple testing: when and how?, J Clin Epidemiol, 54, 343, 10.1016/S0895-4356(00)00314-0 Florence, 2016, The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013, Med Care, 54, 901, 10.1097/MLR.0000000000000625 Wilkerson, 2016, The opioid epidemic in the United States, Emerg Med Clin North Am, 34, e1, 10.1016/j.emc.2015.11.002 Coleski, 2016, Endoscopic gastric food retention in relation to scintigraphic gastric emptying delays and clinical factors, Dig Dis Sci, 61, 2593, 10.1007/s10620-016-4173-7 Fickel, 1997, Opioid receptor expression in the rat gastrointestinal tract: a quantitative study with comparison to the brain, Brain Res Mol Brain Res, 46, 1, 10.1016/S0169-328X(96)00266-5 Tzschentke, 2007, (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel μ-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties, J Pharmacol Exp Ther, 323, 265, 10.1124/jpet.107.126052 Parkman, 2016, Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis, Neurogastroenterol Motil, 28, 1902, 10.1111/nmo.12893 Parkman, 2017, Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing, Neurogastroparesis Motil, 29 Bielefeldt, 2009, Different faces of gastroparesis, World J Gastroenterol, 15, 6052, 10.3748/wjg.15.6052 Anaparthy, 2009, Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors, Dig Dis Sci, 54, 1003, 10.1007/s10620-009-0717-4 Davis, 2010, Palliative Medicine Study Group of the Multinational Association of Supportive Care in Cancer. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation, J Pain Symptom Manag, 39, 756, 10.1016/j.jpainsymman.2009.08.010 Hardy, 2002, A double-blind, randomized, parallel group, multinational, multicenter study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients, Support Care Cancer, 10, 231, 10.1007/s00520-001-0332-1 Torigoe, 2012, Usefulness of olanzapine as an adjunct to opioid treatment and for the treatment of neuropathic pain, Anesthesiology, 116, 159, 10.1097/ALN.0b013e31823c7e56 Okamoto, 2007, A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients, J Pain Symptom Manag, 34, 217, 10.1016/j.jpainsymman.2006.10.020 Foss, 1993, Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs, J Clin Pharmacol, 33, 747, 10.1002/j.1552-4604.1993.tb05618.x Murphy, 1997, Opioid-induced delay in gastric emptying: a peripheral mechanism in humans, Anesthesiology, 87, 765, 10.1097/00000542-199710000-00008 Woo, 2008, Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone, Anesth Analg, 107, 1965, 10.1213/ane.0b013e31818556d3